Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $730.13 billion, total revenue of $168.76 billion and a weighted average PE ratio of 41.74.
Market Cap
730.13B
Revenue
168.76B
Profits
17.49B
PE Ratio
41.74
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 186.32B | -1.00% | 2,423,734 | 45.20B |
| 2 | DHR | Danaher Corporation | 134.82B | -1.19% | 3,471,370 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 41.53B | -1.77% | 763,423 | 4.45B |
| 4 | NTRA | Natera, Inc. | 38.88B | -0.32% | 1,371,547 | 2.50B |
| 5 | A | Agilent Technologies, Inc. | 37.52B | 0.19% | 2,023,313 | 7.23B |
| 6 | WAT | Waters Corporation | 36.82B | 1.67% | 1,480,045 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 32.25B | -0.03% | 1,357,504 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 26.60B | -2.91% | 1,754,660 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 25.82B | 1.48% | 235,029 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 23.46B | -0.32% | 847,823 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 22.96B | 0.15% | 815,565 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 19.89B | -2.41% | 3,380,920 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.12B | -0.96% | 335,552 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 13.31B | 0.42% | 1,067,775 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.41B | 0.04% | 2,512,646 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 10.92B | 0.54% | 1,061,317 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.09B | -1.73% | 2,480,701 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 6.41B | 4.60% | 1,989,292 | 409.48M |
| 19 | BLLN | BillionToOne, Inc. | 5.52B | -0.35% | 532,117 | 354.54M |
| 20 | SHC | Sotera Health Company | 5.06B | 1.31% | 2,012,020 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.85B | 4.03% | 810,536 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.69B | -2.43% | 1,324,124 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.43B | 0.23% | 3,799,376 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 2.93B | -0.18% | 374,430 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 2.04B | -0.68% | 552,159 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.90B | 2.39% | 3,595,296 | 745.97M |
| 27 | CDNA | CareDx, Inc. | 1.47B | -2.66% | 642,716 | 412.82M |
| 28 | PSNL | Personalis, Inc. | 1.40B | -2.55% | 4,099,363 | 64.52M |
| 29 | OPK | OPKO Health, Inc. | 1.13B | -0.66% | 2,328,609 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 723.37M | -1.93% | 336,700 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 582.78M | -0.05% | 251,706 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 539.30M | -2.39% | 1,599,204 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 227.95M | -5.29% | 116,805 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 190.51M | 8.86% | 168,729 | 1.95M |
| 35 | XGN | Exagen Inc. | 112.34M | -2.11% | 205,995 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 88.27M | 3.59% | 14,861 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 44.26M | 2.68% | 16,216 | 25.83M |
| 38 | QUCY | Quantum Cyber N.V. | 23.02M | -1.88% | 1,713,226 | 537.08K |
| 39 | MDXH | MDxHealth SA | 21.09M | 2.65% | 1,059,741 | 110.97M |
| 40 | MBAI | Check-Cap Ltd. | 9.11M | -0.79% | 37,930 | - |
| 41 | XWEL | XWELL, Inc. | 9.04M | 3.88% | 69,314 | 28.83M |
| 42 | ADVB | Advanced Biomed Inc. | 7.68M | -0.43% | 28,889 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 6.77M | 6.60% | 23,404 | - |
| 44 | ISPC | iSpecimen Inc. | 3.81M | -5.02% | 42,575 | 1.03M |
| 45 | BIAF | bioAffinity Technologies, Inc. | 3.68M | 1.05% | 230,066 | 5.66M |